Left thoracoscopic sympathectomy for refractory ventricular arrhythmias
Takahiro Yanagihara1, Naohiro Kobayashi2, Yusuke Saeki1
1Faculty of Medicine, Department of Thoracic Surgery, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
General Thoracic and Cardiovascular Surgery
|June 7, 2022
Summary
Left cardiac sympathetic denervation effectively treats refractory ventricular arrhythmias when medical options fail. This video-assisted thoracotomy approach offers a successful surgical solution for this challenging condition.
Area of Science:
- Cardiology
- Thoracic Surgery
- Autonomic Nervous System
Background:
- Refractory ventricular arrhythmias pose a significant clinical challenge, often persisting despite optimal medical management.
- Left cardiac sympathetic denervation (LCSD) is an established, albeit uncommon, surgical intervention for such cases.
- The procedure typically involves resection of the lower stellate ganglion.
Observation:
- A patient presented with ventricular arrhythmias that were resistant to conventional medical therapies.
- The patient's condition necessitated an alternative treatment strategy.
Findings:
- Successful treatment of refractory ventricular arrhythmias was achieved using left cardiac sympathetic denervation.
- The surgical intervention was performed utilizing a video-assisted thoracotomy approach.
- This minimally invasive technique facilitated the successful resection of the stellate ganglion.
Implications:
- Video-assisted thoracotomy provides a viable and effective surgical option for left cardiac sympathetic denervation.
- This approach may expand the applicability of LCSD for managing complex cardiac arrhythmias.
- Further research into minimally invasive techniques for LCSD is warranted.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
42
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
42
Cardiomyopathy III: Hypertrophic Cardiomyopathy
69
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
69
Dysrhythmias VI: Management of Dysrhythmias
115
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
115
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
177
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
177


